首页> 外国专利> Osmotic pump tablet with controlled porosity of highly permeable drugs and their preparation procedure

Osmotic pump tablet with controlled porosity of highly permeable drugs and their preparation procedure

机译:控释孔隙率高渗透性药物的渗透泵片及其制备方法

摘要

Osmotic pump tablet of controlled porosity of highly permeable drugs, comprising a core and a semipermeable membrane, in which the core comprises a main agent, wherein said main agent is venlafaxine or a pharmaceutically acceptable salt thereof, an enhancer of the permeation and unuxiliar permeation, and the semipermeable membrane comprises a film-forming material and a pore-forming agent, wherein the semipermeable membrane comprises the pore-forming agent in an amount comprised between 20 and 45% by weight of the semipermeable membrane , wherein said depot forming agent is selected from the group consisting of polyethylene glycol with a molecular weight of 2000 to 6000, hydroxypropyl cellulose, and mixtures thereof, and the semipermeable membrane is present in an amount between 10 and 35% in core weight
机译:一种具有高渗透性的药物的孔隙率受控的渗透泵片,其包括芯和半透膜,其中所述芯包含主剂,其中所述主剂是文拉法辛或其药学上可接受的盐,渗透性增强剂和非渗透性增强剂,所述半透膜包含成膜材料和成孔剂,其中所述半透膜包含成孔剂的量为所述半透膜重量的20%至45%,其中所述储库形成剂被选择选自分子量为2000至6000的聚乙二醇,羟丙基纤维素及其混合物,并且半透膜的存在量为核心重量的10%至35%

著录项

  • 公开/公告号ES2446267T3

    专利类型

  • 公开/公告日2014-03-06

    原文格式PDF

  • 申请/专利权人 COSCI MED-TECH CO. LTD.;

    申请/专利号ES20070816581T

  • 发明设计人 WANG JINGANG;JIANG HAISONG;

    申请日2007-10-16

  • 分类号A61K9/22;A61K9;A61K9/20;A61K9/24;A61K9/28;A61K9/30;A61K31/135;A61K31/137;A61P9/10;A61P9/12;A61P25/24;

  • 国家 ES

  • 入库时间 2022-08-21 15:55:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号